`
Thursday, 17 August 2017

Stem Cells News

  • APAC stem cell therapy market to reach $972mn in 2018

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 01 Jan, 2013

    Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to $972 million in 2018, at a c...Read more

  • CardioCel tissue patch enhances stem cell survival

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2013

    Singapore: Australia's Allied Healthcare's CardioCel tissue patches has shown superiority for stem cells survival and growth as compared to the gold-standard tissues in surgical use. Joint...Read more

  • VeriStem wins BioSpectrum award for stem cell technology

    Stem Cells |  Influencers | By Amrita Tejasvi | 0 Comment | 15 Mar, 2013

    Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriStem Technologies of Singapore aims to fulfil this industry need. The c...Read more

  • LifeMap launches embryonic stem cell roadmap

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012

    Sinapore: LifeMap Sciences, subsidiary of BioTime, has launched LifeMap Discovery, a roadmap of embryonic development and stem cell biology. The platform integrates embryonic development an...Read more

  • Will the next blockbuster emerge from Asia?

    Stem Cells |  Opinion | By Nandita Singh | 0 Comment | 17 Oct, 2012

    Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More importantly, will these new examples emerge from companies in Asia? Two years...Read more

  • Bionomics acquires US cancer firm

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2012

    Singapore: Adelaide-based biotechnology company Bionomics has strengthened its presence in the US with the acquisition of a private biotechnology company Eclipse Therapeutics. The company a...Read more

  • Stem cells from skin can cure multiple sclerosis

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2013

    Singapore: A study conducted by Dr Steven Goldman and his team at the University of Rochester Medical Center (URMC), US, has attempted to employ human induced pluripotent stem cells (hiPSC)...Read more

  • Biokine awarded FDA orphan drug designation

    Stem Cells |  Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2012

    Singapore: Biokine Therapeutics received orphan drug designation from the US FDA for the mobilization of hematopoietic stem cells from bone marrow into peripheral blood for collection and s...Read more

  • World's first stem cell-vein implant

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2012

    Singapore: Swedish doctors have for the first time in history been able to pair the groin vein of a dead donor with stem cells from a young girl. The pairing was followed by the successful ...Read more

  • Osiris successfully defends patent challenge in Australia

    Stem Cells |  Regulatory | By BioSpectrum Bureau | 0 Comment | 26 Feb, 2013

    Singapore: Osiris Therapeutics, a Columbia-based company focused on developing and marketing stem cell products to treat serious medical conditions, has successfully defended a patent chall...Read more

  • Orthocell gets ASX listing, plans to raise $8mn initially

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 29 May, 2014

    Singapore: Australian regenerative medicine firm, Orthocell, is looking ahead to raise $8 million through an Initial Public Offer (IPO) of 20 million shares to be listed on the Australian S...Read more

  • Japan approves pioneering stem cell study for heart disease

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2012

    Singapore: Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical study in Japan using the Celution System has been approved under the Min...Read more

  • Mesoblast to set up stem cell drug plant in Singapore

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 29 May, 2014

    Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the company is in dialogues with Singapore Economic Development Board (ED...Read more

  • Korean stem cells that can be transformed into organs

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2012

    Singapore: Korean scientists have developed a breakthrough technology that can more efficiently and safely reprogram adult cells to an embryo-like state, which can then in-turn be programme...Read more

  • Japan scientists pioneer new stem cell technology

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012

    Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

  • Australian firm registers 25 disease specific stem cell lines at NIH

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

    Singapore: Australia's Genea Stem Cells, a supplier and developer of disease-specific human stem cells, has been successful in registering 25 of its disease specific embryonic pluripotent s...Read more

  • Skin cancer promoting gene discovered

    Stem Cells |  News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2012

    Singapore: Researchers from the University of Zurich have discovered a gene that plays a central role in black skin cancer or melanoma. Suppressing this gene in mice inhibits the developmen...Read more

  • New Zealand approves stem cell drug Prochymal

    Stem Cells |  Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Jun, 2012

    Singapore: Osiris Therapeutics has received consent from New Zealand to market its first-in-class stem cell therapy Prochymal (remestemcel-L) for the treatment of acute graft-vs-host diseas...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls